Showing results (301-310 of 11,327) with videos related to
Sort By:
Pageof 1,133
Thrombosis and Haemostasis|February 10, 2012
Dabigatran etexilate for stroke prevention in patients with atrial fibrillation: resolving uncertainties in routine practiceMenno V Huisman, Gregory Y H Lip, Hans-Christoph Diener, et al.Thrombosis and Haemostasis|March 9, 2012
Oral anticoagulation use by patients with atrial fibrillation in Germany. Adherence to guidelines, causes of anticoagulation under-use and its clinical outcomes, based on claims-data of 183,448 patientsThomas Wilke, Antje Groth, Sabrina Mueller, et al.Thrombosis and Haemostasis|March 9, 2012
Molecular analysis and genotype-phenotype correlation in patients with antithrombin deficiency from Southern ItalyG Castaldo, A M Cerbone, A Guida, et al.Thrombosis and Haemostasis|February 29, 2012
GPIIb/IIIa inhibitors: from bench to bedside and back to bench againPaul C Armstrong, Karlheinz PeterThrombosis and Haemostasis|February 29, 2012
Micro-array profiling exhibits remarkable intra-individual stability of human platelet micro-RNAC Stratz, T G Nührenberg, H Binder, et al.Thrombosis and Haemostasis|September 4, 2008
Should female relatives of factor V Leiden carriers be screened prior to oral contraceptive use? A cost-effectiveness analysisKenneth J Smith, Brenna S Monsef, Margaret V RagniThrombosis and Haemostasis|September 4, 2008
Intermittent intravenous urokinase for critical limb ischemia in diabetic foot ulcerationMatthias Weck, Hannes Rietzsch, Holger Lawall, et al.Thrombosis and Haemostasis|September 4, 2008
Simvastatin-induced endothelial cell detachment and microparticle release are prenylation dependentMichaela Diamant, Maarten E Tushuizen, Mohammed N Abid-Hussein, et al.Thrombosis and Haemostasis|May 6, 1991
Three distinct point mutations in the factor IX gene of three Japanese CRM+ hemophilia B patients (factor IX BMNagoya 2, factor IX Nagoya 3 and 4)M Hamaguchi, T Matsushita, M Tanimoto, et al.Thrombosis and Haemostasis|May 6, 1991
Recommendations for the evaluation and treatment of neonatal autoimmune and alloimmune thrombocytopenia. The Working Party on Neonatal Immune Thrombocytopenia of the Neonatal Hemostasis Subcommittee of the Scientific and Standardization Committee of the ISTHJ Bussel, C Kaplan, J McFarlandPageof 1,133